OPKO Completes Patient Enrollment in Third Phase 3 Trial of RAYALDEEâ„¢

[Business Wire] – OPKO Health, Inc. , has completed patient enrollment in the third phase 3 trial of RAYALDEE. This trial is designed to evaluate the product’s long-term safety and effica more

View todays social media effects on OPK

View the latest stocks trending across Twitter. Click to view dashboard

See who OPKO is hiring next, click here to view